O'Shaughnessy Asset Management, LLC Novo Cure LTD Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $104,511 - $169,810	-1,392 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$116.17 - $194.55 $445,163 - $745,515	-3,832 Reduced 73.35%	1,392 $162,000
Q2 2021 Aug 09, 2021	BUY	$130.4 - $225.58 $57,506 - $99,480	441 Added 9.22%	5,224 $1.16 Million
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $429,544 - $658,178	3,461 Added 261.8%	4,783 $632,000
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $142,331 - $220,983	1,269 Added 2394.34%	1,322 $229,000
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $66,235 - $127,004	-1,141 Reduced 95.56%	53 $6,000
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $81,550 - $111,997	1,194 New	1,194 $100,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.